Sign In to Follow Application
View All Documents & Correspondence

Healthcare Platform For Managing Polycystic Ovary Syndrome (Pcos) And Polycystic Ovarian Disease (Pcod)

Abstract: ABSTRACT The present invention relates to a healthcare platform for managing PCOS and PCOD comprises a symptom tracking module configured to monitor and record symptoms of a user related to PCOS and PCOD, a medical information module capable of providing evidence based information that is specific for a user having different symptoms and health status; a lifestyle recommendation module capable of providing suggestions regarding changes required in lifestyle of the user and different strategies to manage the PCOS and PCOD symptoms, a telemedicine consultation module capable of allowing the user to seek consultation from both an Ayurveda consultants and allopathic consultants; a community support module enables the user to connect with a community for an emotional support and informational support and a user interface allows women across the world to use the platform effectively.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
02 September 2024
Publication Number
38/2024
Publication Type
INA
Invention Field
BIO-MEDICAL ENGINEERING
Status
Email
Parent Application

Applicants

Jaipuria Institute of Management
Indirapuram Ghaziabad, Block-A, Gate No.2, Shakti Khand IV, Indirapuram Ghaziabad Uttar Pradesh India 201014

Inventors

1. Mansi Singh
Jaipuria Institute of Management, Indirapuram Ghaziabad, Block-A, Gate No.2, Shakti Khand IV, Indirapuram Ghaziabad Uttar Pradesh India 201014
2. Dr. Rashmi Bhatia
Jaipuria Institute of Management, Indirapuram Ghaziabad, Block-A, Gate No.2, Shakti Khand IV, Indirapuram Ghaziabad Uttar Pradesh India 201014
3. Dr Himanshu Sharma
Jaipuria Institute of Management, Indirapuram Ghaziabad, Block-A, Gate No.2, Shakti Khand IV, Indirapuram Ghaziabad Uttar Pradesh India 201014

Specification

Description:FIELD OF THE INVENTION

[0001] The present invention relates to a healthcare platform for managing Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD) that is capable of providing a user both allopathic and Ayurveda consultations based upon their choices.

BACKGROUND OF THE INVENTION

[0002] Polycystic ovarian syndrome (PCOS) is a disease occurring in females, and is characterized by hyperandrogenism. PCOS represents a spectrum of phenotypes associated with follicle growth arrest, chronic anovulation, minimal granulosa cell proliferation, hyperthecosis, hyperandrogenemia, central adiposity and insulin resistance. In PCOS, plasma luteinizing hormone (LH) is high and FSH is low, increasing the LH/FSH ratio, typically due to increased LH or GnRH (Gonadotropin releasing hormone) pulse. In PCOS, disturbances occur in ovarian steroid synthesis, hyperinsulinemia being one of the condition which increases ovarian androgen production and stimulate LH and increases LH/GnRH secretion. A neuroendocrine defect of GnRH secretion leads to persistent hypersecretion of LH in non-obese PCOS patients. Many females with PCOS suffer from menstrual cycle abnormalities, hirsutism and infertility.

[0003] There are no approved treatments for PCOS. Optimal first line treatment of PCOS in adolescents remains controversial. Lifestyle changes (dietary and exercise modification) followed by either oral contraceptive pills (OCP) to control symptoms of hyperandrogenism is normally recommended, which has not more than 50% clinical success. However, there is significant variability in clinical practice, depending on whether the physician and patient’s primary goal of treatment is to treat the symptoms of hyperandrogenism or the features of metabolic syndrome. Additionally, in clinical practice anti-androgenic medications such as spironolactone, flutamide, and insulin sensitizing agents such as metformin or pioglitazone are used as add-on therapy when OCP or metformin fail to produce the clinically desired outcomes, yet their use in adolescent population is not recommended. Anti-androgens like spironolactone are second choice having risk of electrolyte imbalance. GnRH analogue is the next line of therapy to reduce androgen with lack of potency needing additional hormonal therapy to counteract the chemical menopause that they induce. Metformin may be administered to reduce androgen level, improve menstrual regularity and fertility as well as insulin resistance. Clomiphene with or without metformin improves conception rates with risk of ovarian hyperstimulation and multiple. Increased prevalence of NAFLD has been reported in patients with polycystic ovary syndrome (PCOS), one of the most common endocrinopathies in premenopausal women, which has been redefined as a reproductive and metabolic disorder after the recognition of the important role of insulin resistance in the pathophysiology of the syndrome. Obesity, in particular central adiposity and insulin resistance are considered as the main factors related to NAFLD in PCOS. Although the natural history of NAFLD remains unclear and hepatic steatosis seems to be a relatively benign condition in most patients, limited data imply that advanced stage of liver disease is possibly more frequent in obese PCOS patients with NAFLD.

[0004] Since current treatment strategies for PCOS have limited efficacy and marked side effects, and further there are no consistent guidelines for their uses, a therapeutic option which can cure the underlying pathophysiology related to hypothalamic pituitary gonadal (HPG) axis, correct the LH pulsatility, and treat the symptoms of metabolic disturbances without significant side effects is needed. Thus, there exists a need for newer therapies for the treatment of polycystic ovarian syndrome (PCOS).

[0005] US6034075A discloses a method of treating polycystic ovarian syndrome (PCO) with calcium alone, with vitamin D alone, or with the combination calcium and vitamin D. This invention further provides a method of treating infertility in a woman which comprises administering to the subject an amount of calcium or a derivative thereof effective to treat the infertility. The present invention is also directed to a method of treating irregular menses (oligo/amenorrhea), acne, or hirsutism, insulin resistance, or infertility which comprises administering a combination of calcium or a derivative thereof and vitamin D or a derivative thereof in an amount effective to treat irregular menses (oligo/amenorrhea), acne, or hirsutism, insulin resistance, or infertility. This invention also provides a method of preventing polycystic ovarian syndrome which comprises administering to the subject a combination of vitamin D or a derivative thereof and calcium or a derivative thereof in an amount effective to prevent the onset of polycystic ovarian syndrome.

[0006] Conventionally, many platform have been mentioned in the prior arts, that is capable of providing consultation to but still none of the existing platforms are capable of determining symptoms related to PCOS and PCOD and deliver consultation based upon the determined symptom, or providing the user suffering from PCOS and PCOD both a mental and physical support.

[0007] In order to overcome the aforementioned drawbacks, there is a requirement to develop a platform that is capable of determining symptoms related to PCOS and PCOD and deliver consultation based upon the determined symptom, or providing the user suffering from PCOS and PCOD both a mental and physical support.

OBJECTS OF THE INVENTION

[0008] The principal object of the present invention is to overcome the disadvantages of the prior art.

[0009] An object of the present invention is to develop a platform that is capable of determining symptoms related to PCOS and PCOD.

[0010] Another object of the present invention is to develop a platform that is capable delivering consultation based upon the determined symptom, thereby aiding the user to recover from PCOS and PCOD.

[0011] Yet another object of the present invention is to develop a platform that is capable of providing the user suffering from PCOS and PCOD both a mental and physical support.

[0012] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.

SUMMARY OF THE INVENTION

[0013] The present invention relates to a healthcare platform for managing Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD), capable of providing consultation to a user based upon detected symptoms.

[0014] According to an embodiment of the present invention, a healthcare platform for managing Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD) comprises a symptom tracking module configured to monitor and record symptoms of a user related to PCOS and PCOD, a medical information module capable of providing evidence based information that is specific for a user having different symptoms and health status; a lifestyle recommendation module capable of providing suggestions regarding changes required in lifestyle of the user and different strategies to manage the PCOS and PCOD symptoms, a telemedicine consultation module capable of allowing the user to seek consultation from both an Ayurveda consultants and allopathic consultants; a community support module enables the user to connect with a community for an emotional support and informational support.

[0015] According to another embodiment of the present invention, the proposed platform further comprises a a user interface allows women across the world to use the platform effectively, thereby empowering woman to remain informed and take decisions accordingly and manage their health in an effective manner, the tracking module is communicably coupled with wearable devices for determining physical parameters related to the PCOS and PCOD that includes body temperature, heart rate and menstrual cycle patters, the recommendation module updates recommendation on a real time basis, the information module provided update on a real time basis regarding guidelines that are required to be followed in PCOS and PCOD.

[0016] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

[0017] These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
Figure 1 illustrates a block diagram of a healthcare platform for managing Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD).

DETAILED DESCRIPTION OF THE INVENTION

[0018] The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.

[0019] In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.

[0020] As used herein, the singular forms “a,” “an,” and “the” designate both the singular and the plural, unless expressly stated to designate the singular only.

[0021] The present invention relates to a healthcare platform for managing Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD) capable of determining symptoms of a user and provide suggestion for maintaining the same in order to aid the user to recover from PCOS or PCOD.

[0022] Referring to Figure 1, illustrates a block diagram of a healthcare platform for managing Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD).

[0023] The present invention relates to a personalized healthcare platform for women, tailored to help them manage PCOS and PCOD. It shall comprise several modules, which will work together in order to realize a comprehensive, user-centered approach toward the management of these life conditions by putting tools and resources at the user's fingertips. It is meant to support, educate, and provide women with the tools and assistance necessary for them to understand their condition better, manage symptoms, and make informed choices about their health.

[0024] The symptom tracking module represents a vital component of the platform while permitting users to assess and store an individual’s symptoms relating to PCOS and PCOD. It is programmed to track symptoms including irregular menstrual cycle, weight changes, acne, hair loss, and other physical and mood symptoms. To improve the accuracy and ease for symptom tracking there is capability to integrate with wearable devices which manage the physical parameters in an automated way- these include body temperature, heart rate, and pattern of menstrual cycle in real-time and then embedded in the user’s profile. Data collected are then utilized to determine trends and to engage alerts if any abnormal trends are reported- enabling prompt action.

[0025] The medical information module is capable of providing users actual and individualized piece of advice based on their symptoms and general condition. This module connects with a vast repository of medical literature and guidelines about PCOS and PCOD treatment. It is constantly being revised and therefore contains the most up-to-date research and medical advice that the users can get. The module provides the user with relevant and focused content in the form of educational articles and videos, and opinions from professionals based on user’s needs and symptoms. As a result, users will become equipped with the information they want about their condition and the existing cure or therapy.

[0026] The lifestyle recommendation module gives personalized changes and strategies in lifestyle that help a woman manage symptoms of PCOS and PCOD. Recommendations will follow tracked symptoms, health data, and personal preferences of the user. This module is set to update recommendations in real time and thus adapt to changes in the user's condition. For example, the lifestyle module may recommend diet changes, exercise regimen, or stress-releasing techniques if the symptom tracking module identifies a pattern that points to irregular menstrual cycles. This module also keeps in perspective the cultural background, preference, and lifestyle of the users to make recommendations feasible and reproducible in daily life.

[0027] Users can access consultations from Ayurvedic and Allopathic practitioners through the telemedicine consultation module, offering a range of treatment options enabling the user to select their preferred treatment model for themselves. The module includes a scheduling tool based on different time zones that let users book appointments at their preferred times; the module also includes profiles of practitioners with details of their experience, treatment style, and user reviews to support the user in reviewing their available health care options. When Ayurvedic and Allopathic are offered in one module, it offers a broader approach to manage PCOS and PCOD and demonstrates the varied needs of women worldwide.

[0028] To facilitate better users engagement the community support module will enable and encourage users to share their experiences with other users and as well get support from other users. This module has a forum option to enable users post their stories regarding their health, and is designed to be anonymous, making users post their information from their comfort without revealing their identity to anyone. The community module also provides points of discussion, webinars and Q&As with professionals as well as with other users who may be experiencing similar issues. Being able to enhance the feeling of togetherness, this particular module will also assist in the minimization of loneliness that stems from chronic diseases treatment..

[0029] The platform offers an interface that can access and assist women globally and from multiple locations. The interface is easy to use and very intuitive, allowing users to follow the platform easily. The interface also has a multilingual option to make it easier for women who do not speak English, allowing them to access all the information and features throughout the platform in their preferred language. This allows the platform to be useful for a wider group of women across the globe regardless of language and where they live.

[0030] Overall, the platform offers women with PCOS and PCOD a comprehensive and custom healthcare option. Streamlining the ability to track symptoms, provide evidence-based medicine recommendations, a personalized lifestyle option, as well as both telemedicine or traditional options, and community supports. Users at home can take back control of their health. There are Ayurvedic and Allopathic treatment options with various options for consultation types-users can make an informed choice about services which best meets their personal preferences and needs. The platform's ability to reach and assist women worldwide, in universal access and the multilingual option, enhances the users' experience and ability to tap into the usage throughout the world and promote well-being women living with PCOS and PCOD.

[0031] Although the field of the invention has been described herein with limited reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention.
, Claims:We Claim:
1) A healthcare platform for managing Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD), comprising:
a) a symptom tracking module associated with said platform, wherein said tracking module is configured to monitor and record symptoms of a user related to PCOS and PCOD;
b) a medical information module associated with said platform, wherein said platform is capable of providing evidence based information that is specific for a user having different symptoms and health status;
c) a lifestyle recommendation module associated within said platform, wherein said recommendation module is capable of providing suggestions regarding changes required in lifestyle of said user and different strategies to manage said PCOS and PCOD symptoms;
d) a telemedicine consultation module associated with said platform, wherein said consultation module is capable of allowing said user to seek consultation from both an Ayurveda consultants and allopathic consultants;
e) a community support module associated with said platform, wherein said support module enables said user to connect with a community for an emotional support and informational support; and
f) a user interface associated with said platform allows women across the world to use said platform effectively, thereby empowering woman to remain informed and take decisions accordingly and manage their health in an effective manner.

2) The platform as claimed in claim 1, wherein, said tracking module is communicably coupled with wearable devices for determining physical parameters related to said PCOS and PCOD that includes body temperature, heart rate and menstrual cycle patters.

3) The platform as claimed in claim 1, wherein said recommendation module updates recommendation on a real time basis.

4) The platform as claimed in claim 1, wherein said information module provided update on a real time basis regarding guidelines that are required to be followed in PCOS and PCOD.

Documents

Application Documents

# Name Date
1 202411066267-STATEMENT OF UNDERTAKING (FORM 3) [02-09-2024(online)].pdf 2024-09-02
2 202411066267-REQUEST FOR EARLY PUBLICATION(FORM-9) [02-09-2024(online)].pdf 2024-09-02
3 202411066267-POWER OF AUTHORITY [02-09-2024(online)].pdf 2024-09-02
4 202411066267-FORM-9 [02-09-2024(online)].pdf 2024-09-02
5 202411066267-FORM FOR SMALL ENTITY(FORM-28) [02-09-2024(online)].pdf 2024-09-02
6 202411066267-FORM 1 [02-09-2024(online)].pdf 2024-09-02
7 202411066267-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [02-09-2024(online)].pdf 2024-09-02
8 202411066267-EVIDENCE FOR REGISTRATION UNDER SSI [02-09-2024(online)].pdf 2024-09-02
9 202411066267-EDUCATIONAL INSTITUTION(S) [02-09-2024(online)].pdf 2024-09-02
10 202411066267-DRAWINGS [02-09-2024(online)].pdf 2024-09-02
11 202411066267-DECLARATION OF INVENTORSHIP (FORM 5) [02-09-2024(online)].pdf 2024-09-02
12 202411066267-COMPLETE SPECIFICATION [02-09-2024(online)].pdf 2024-09-02